Pathologie pp 301-346 | Cite as

Genetische Stoffwechselerkrankungen mit neuropathologischer Bedeutung

  • K. Harzer
  • N. Breitbach

Zusammenfassung

Es ist unmöglich, in einem kurzen Beitrag alle beschriebenen, neurologisch oder neuropathologisch bedeutsamen Krankheiten mit gesicherter oder vermuteter genetischer Ursache zu berücksichtigen oder auch nur zu streifen. Vereinfachend gesagt, wirkt sich jede genetische Störung, soweit sie in den überregionalen Stoffwechsel eingreift (und das ist eher die Regel als die Ausnahme), auf das Nervensystem aus, ganz abgesehen von der großen Zahl genetischer Störungen, öie schon primär im Nervengewebe wichtige Stoffwechselschritte betreffen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams JH, Duchen LW (eds) (1992) Greenfield’s neuropathology.5th ed. Arnold/Hodder & Stoughton, LondonGoogle Scholar
  2. 2.
    Baumann N, Federico A, Suzuki K (eds) (1991) Late onset neurometabolic genetic disorders. From clinical to molecular aspects of lysosomal and peroxisomal disease. Dev Neurosci 13: 185–376CrossRefGoogle Scholar
  3. 3.
    Cervós-Navarro J (1991) Pathologie des Nervensystems. Y.Degenerative und metabolische Erkrankungen. Redigiert von H. Berlet. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  4. 4.
    Friede RL (1989) Developmental neuropathology, part 3: Metabolic diseases. Springer, Berlin Heidelberg New York Tokyo, pp 405–560Google Scholar
  5. 5.
    Hansen HG, Graucob E (1985) Hematologic cytology of storage diseases. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  6. 6.
    Janisch W, Schreiber D, Warzog R (1990) Neuropathologie – Pathomorphologie und Pathogenese neurologischer Krankheiten. Fischer, Stuttgart New YorkGoogle Scholar
  7. 7.
    Peiffer J (1984) Angeborene Stoffwechselkrankheiten. Neuropathologischer Teil. In: Remmele W, (Hrsg) Pathologie. Springer, Berlin Heidelberg New York Tokyo, S 479–533Google Scholar
  8. 8.
    Scriver CR, Beaudet AL, Sly WS, Valle D (eds) (1995) The metabolic basis of inherited disease. 7th ed. McGraw-Hill, New York (in press)Google Scholar
  9. 9.
    Tada K, Colombo JB, Desnick RJ (1987) Recent advances in inborn errors of metabolism. Enzyme 38: 7–327Google Scholar
  10. 10.
    Becker LE (1992) Lysosomes, peroxisomes and mitochondria: function and disorder. Am J Neuroradiol 13: 609–620PubMedGoogle Scholar
  11. 11.
    Blennow G, Jaeken J, Wiklund LM (1991) Neurological findings in the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand 5 [SuppI375]: 14--20CrossRefGoogle Scholar
  12. 12.
    Breningstall GN (1990) Carnitine deficiency syndromes. Pediatr Neurol 6: 75–81PubMedCrossRefGoogle Scholar
  13. 13.
    Bu X, Rotter JI (1991) X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: Evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci USA 88: 8198–8202PubMedCrossRefGoogle Scholar
  14. 14.
    Byrd DJ, Krohn HP, Winkler L, Steinborn C, Hadam M, Brodehl J, Hunneman DH (1989) Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemia. Eur J Pediatr 148: 543–547PubMedCrossRefGoogle Scholar
  15. 15.
    Carpenter S (1988) Morphological diagnosis and misdiagnosis in Batten-Kufs disease. Am J Med Genet [SuppI5]: 85–91Google Scholar
  16. 16.
    Ceuterick C, Martin JJ (1992) Electron microscopic features of skin in neurometabolic disorders. J Neurol Sci 112: 15–29PubMedCrossRefGoogle Scholar
  17. 17.
    Dening TR, Berrios GE (1989) Wilson’s disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry 46: 1126-1134PubMedCrossRefGoogle Scholar
  18. 18.
    DeVivo DC, DiMauro S (1990) Mitochondrial defects of brain and muscle. Bioi Neonate 58 [Suppl1]: 54–69CrossRefGoogle Scholar
  19. 19.
    Goebel HH (1992) Neuronal ceroid-lipofuscinoses: The current status. Brain Dev 14: 203–211PubMedGoogle Scholar
  20. 20.
    Hagberg B (1990) Polyneuropathies in paediatrics. Eur J Pediatr 149:296--305PubMedCrossRefGoogle Scholar
  21. 21.
    Hale DE, Bennett MJ (1992) Fatty acid oxidation disorders: A new class of metabolic diseases. J Pediatr 121: 1–11PubMedCrossRefGoogle Scholar
  22. 22.
    Harpey JP, Charpentier C, Paturneau-Jouas L (1990) Sudden infant death syndrome and inherited disordes of fatty acid β-oxidation. Bioi Neonate 58 [Suppll]: 70–80CrossRefGoogle Scholar
  23. 23.
    Harzer K, Paton BC, Poulos A, Kustermann-Kuhn B, Roggendorf W, Grisar T, Popp M (1989) Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr 149: 31–39PubMedCrossRefGoogle Scholar
  24. 24.
    Hoffmann GF, Jakobs C, Rating D, Sweetman L, Trefz FK (1990) Prä- und postnatale Diagnostik der Organoazidopathien. Monatsschr Kinderheilkd 138: 381–388PubMedGoogle Scholar
  25. 25.
    Jaeken J, Klocker H, Schwaiger H, Bellmann R, Hirsch-Kaufmann M, Schweiger M (1989) Clinical and biochemical studies in three patients with severe early infantile Cockayne syndrome. Hum Genet 83: 339–346PubMedCrossRefGoogle Scholar
  26. 26.
    Jellinger K, Armstrong D, Zoghbi HY, Percy AK (1988) Neuropathology of Rett syndrome. Acta Neuropathol 76: 142–158PubMedCrossRefGoogle Scholar
  27. 27.
    Johnson VP, Carpenter NJ, Kelts KA (1991) Pelizaeus-Merzbacher disease:clinical and DNA-linkage study of an extended family. Am J Med Genet 41:355–361PubMedCrossRefGoogle Scholar
  28. 28.
    Kendall BE (1992) Disorders of Iysosomes, peroxisomes, and mitochondria. Am J Neuroradiol 13: 621–653PubMedGoogle Scholar
  29. 29.
    Kennaway NG, Stankova L, Wirtz MK, Weleber RG (1989) Gyrate atrophy of the choroid and retina: characterization of mutantornithine aminotransferase and mechanism of response to vit amin B6. Am J Hum Genet 44: 344–352PubMedGoogle Scholar
  30. 30.
    Lichter-Konecki U, Schlotter M, Trefz FK, Konecki DS (1989) Direct detection of a major mutation responsible for phenylketonuria in the population of the Federal Republic of Germany. Eur J Pediatr 149: 120–123PubMedCrossRefGoogle Scholar
  31. 31.
    Moizer B, Stöckier S, Bernheimer H (1992) Peroxisomale neurologische Krankheiten und M. Refsum: Überlangkettige Fettsauren und Phytänsaure als diagnostische Marker. Wien Klin Wochenschr 104: 665–670Google Scholar
  32. 32.
    Mühlendahl KE von, Lehnert W, Mönch E (1990) MediumChain- Acyl-CoA-Dehydrogenase (MCAD)-Defekt. Akute zerebrale Episoden und nicht-ketotische Hypoglykämien bei Kindem. Dtsch Med Wochenschr 115: 1235–1238CrossRefGoogle Scholar
  33. 33.
    Neufeld EF (1991) Lysosomal storage diseases. Ann Rev Biochern 60: 257–280CrossRefGoogle Scholar
  34. 34.
    Nyhan WL (1988) MUltiple carboxylase deficiency. Int J Biochem 20:363–370PubMedCrossRefGoogle Scholar
  35. 35.
    Peiffer J (1982) Angeborene StöffwechselstOrungen mit bevorzugter Lokalisation im Zentralnervensystem. Verh Dtsch Ges Pathol 66: 213–233PubMedGoogle Scholar
  36. 36.
    Reichmann H, Gold R (1992) Metabolische Myopathien und Enzephalomyopathien. Dt Ärztebl Al 89: 1862–1866Google Scholar
  37. 37.
    Rizzo WB, Craft DA (1991) Sjögren-Larsson syndrome. J Clin Invest 88: 1643–1648PubMedCrossRefGoogle Scholar
  38. 38.
    Royce PM, Steinmann B (1990) Markedly reduced activity of Iysyl oxidase in skin and aorta from a patient with Menkes’ disease showing unusually severe connective tissue manifestations. Pediatr Res 28: 137–141PubMedGoogle Scholar
  39. 39.
    Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, Brophy P, Nave KA (1992) Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358: 758–761PubMedCrossRefGoogle Scholar
  40. 40.
    Servidei S, Bonilla E, Diedrich RG, Kornfeld M, Oates JD, Davidson M, Vora S, DiMauro S (1986) Fatal infantile form of muscle phosphofructokinase deficiency. Neurology 36: 1465–1470PubMedGoogle Scholar
  41. Tanaka K, Koyama A, Koike R, Ohno T, Atsumi T, Miyatake T(1985) Adrenomyeloneuropathy: report of a family and electron microscopical findings in peripheral nerve. J Neuro1 232: 73–78Google Scholar
  42. 42.
    Tanaka K, Yamano T, Shimada M, Ohno M, Onaga A, Saeki Y, Kodama S, Nishio H (1987) Electronmicroscopic study on biopsied rectal mucosa in adrenoleukodystrophy. Neurology 37: 1012–1015PubMedGoogle Scholar
  43. 43.
    Taniike M, Fujimura H, Kogaki S, Tsukamoto H, Inui K, Midorikawa M, Nishimoto J, Okada S (1992) A case of pigmentary type of orthochromatic leUkodystrophy with early onset and globoid cells. Acta Neuropathol 83: 427–433PubMedCrossRefGoogle Scholar
  44. 44.
    Walter S, Goebel HH (1988) Ultrastructural pathology of dermal axons and Schwann cells in lysosomal diseases. Acta Neuropathol 76:489–495PubMedCrossRefGoogle Scholar
  45. 45.
    Wanders RJA, Heymans HSA, Schutgens RBH, Barth PG, van den Bosch H, Tager JM (1988) Peroxisomal disorders in neurology. J Neurol Sci 88: 1–39PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • K. Harzer
  • N. Breitbach

There are no affiliations available

Personalised recommendations